BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15296435)

  • 1. A software tool to assist business-process decision-making in the biopharmaceutical industry.
    Mustafa MA; Washbrook J; Lim AC; Zhou Y; Titchener-Hooker NJ; Morton P; Berezenko S; Farid SS
    Biotechnol Prog; 2004; 20(4):1096-102. PubMed ID: 15296435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medium term planning of biopharmaceutical manufacture using mathematical programming.
    Lakhdar K; Zhou Y; Savery J; Titchener-Hooker NJ; Papageorgiou LG
    Biotechnol Prog; 2005; 21(5):1478-89. PubMed ID: 16209554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A tool for modeling strategic decisions in cell culture manufacturing.
    Farid SS; Novais JL; Karri S; Washbrook J; Titchener-Hooker NJ
    Biotechnol Prog; 2000; 16(5):829-36. PubMed ID: 11027178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A decision-support model for evaluating changes in biopharmaceutical manufacturing processes.
    Chhatre S; Francis R; O'Donovan K; Titchener-Hooker NJ; Newcombe AR; Keshavarz-Moore E
    Bioprocess Biosyst Eng; 2007 Jan; 30(1):1-11. PubMed ID: 17093973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody capture from corn endosperm extracts by packed bed and expanded bed adsorption.
    Menkhaus TJ; Glatz CE
    Biotechnol Prog; 2005; 21(2):473-85. PubMed ID: 15801788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Software Tool to Assist Business-Process Decision-Making in the Biopharmaceutical Industry.
    Mustafa MA; Washbrook J; Lim AC; Zhou Y; Titchener-Hooker NJ; Morton P; Berezenko S; Farid SS
    Biotechnol Prog; 2005 Feb; 21(1):320. PubMed ID: 15913287
    [No Abstract]   [Full Text] [Related]  

  • 7. Multiobjective long-term planning of biopharmaceutical manufacturing facilities.
    Lakhdar K; Savery J; Papageorgiou LG; Farid SS
    Biotechnol Prog; 2007; 23(6):1383-93. PubMed ID: 17924645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of a decision-support tool to assess pooling strategies in perfusion culture processes under uncertainty.
    Lim AC; Zhou Y; Washbrook J; Sinclair A; Fish B; Francis R; Titchener-Hooker NJ; Farid SS
    Biotechnol Prog; 2005; 21(4):1231-42. PubMed ID: 16080707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decision-support software for the industrial-scale chromatographic purification of antibodies.
    Chhatre S; Thillaivinayagalingam P; Francis R; Titchener-Hooker NJ; Newcombe AR; Keshavarz-Moore E
    Biotechnol Prog; 2007; 23(4):888-94. PubMed ID: 17630695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model-based drug development survey finds pharmacometrics impacting decision making in the pharmaceutical industry.
    Stone JA; Banfield C; Pfister M; Tannenbaum S; Allerheiligen S; Wetherington JD; Krishna R; Grasela DM
    J Clin Pharmacol; 2010 Sep; 50(9 Suppl):20S-30S. PubMed ID: 20881214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of agent-based system for bioprocess description and process improvement.
    Gao Y; Kipling K; Glassey J; Willis M; Montague G; Zhou Y; Titchener-Hooker NJ
    Biotechnol Prog; 2010; 26(3):706-16. PubMed ID: 20014420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decision tables in process control: a powerful development tool.
    Nixon JS; McMullen WL
    ISA Trans; 1986; 25(4):55-85. PubMed ID: 3793427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decision-support tool for assessing biomanufacturing strategies under uncertainty: stainless steel versus disposable equipment for clinical trial material preparation.
    Farid SS; Washbrook J; Titchener-Hooker NJ
    Biotechnol Prog; 2005; 21(2):486-97. PubMed ID: 15801789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical process research and development in the 21st century: challenges, strategies, and solutions from a pharmaceutical industry perspective.
    Federsel HJ
    Acc Chem Res; 2009 May; 42(5):671-80. PubMed ID: 19338294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case study and application of process analytical technology (PAT) towards bioprocessing: use of on-line high-performance liquid chromatography (HPLC) for making real-time pooling decisions for process chromatography.
    Rathore AS; Yu M; Yeboah S; Sharma A
    Biotechnol Bioeng; 2008 Jun; 100(2):306-16. PubMed ID: 18078292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medium term planning of biopharmaceutical manufacture with uncertain fermentation titers.
    Lakhdar K; Farid SS; Titchener-Hooker NJ; Papageorgiou LG
    Biotechnol Prog; 2006; 22(6):1630-6. PubMed ID: 17137311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanded bed adsorption/desorption of proteins with Streamline Direct CST I adsorbent.
    Li P; Xiu G; Mata VG; Grande CA; Rodrigues AE
    Biotechnol Bioeng; 2006 Aug; 94(6):1155-63. PubMed ID: 16572450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring shared decision making in the consultation: a comparison of the OPTION and Informed Decision Making instruments.
    Weiss MC; Peters TJ
    Patient Educ Couns; 2008 Jan; 70(1):79-86. PubMed ID: 17942270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Framework for use of toxicity screening tools in context-based decision-making.
    Doull J; Borzelleca JF; Becker R; Daston G; DeSesso J; Fan A; Fenner-Crisp P; Holsapple M; Holson J; Craig Llewellyn G; MacGregor J; Seed J; Walls I; Woo YT; Olin S
    Food Chem Toxicol; 2007 May; 45(5):759-96. PubMed ID: 17215066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.